Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion description "[The abnormal transcription of TACSTD2 and S100A2 are thought to be unique molecular markers of the preinvasive stage of lung adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion evidence source_evidence_literature NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion SIO_000772 16232198 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion wasDerivedFrom befree-20140225 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_assertion wasGeneratedBy ECO_0000203 NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP851001.RAS1_FRe7IKa8s3FDLWbH1yIPe3RMC-M6AjIc20VYK6f4130_provenance.